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Mycobacterium tuberculosis (Mtb) is thought to live in an altered phagosomal environ-
ment. In this setting, the mechanisms by which mycobacterial antigens access the major
histocompatibility class I (MHC-I) processing machinery remain incompletely understood.
There is evidence that Mtb antigens can be processed in both endocytic and cytosolic envi-
ronments, with different mechanisms being proposed for how Mtb antigens can access
the cytosol. Recently, electron microscopy was used to demonstrate that Mtb has the
potential to escape the phagosome and reside in the cytosol. This was postulated as the
primary mechanism by which Mtb antigens enter the MHC-I processing and presentation
pathway. In this commentary, we will review data on the escape of Mtb from the cytosol
and whether this escape is required for antigen presentation to CD8+ T cells.
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INTRODUCTION
Mycobacterium tuberculosis (Mtb) remains a highly prevalent and
successful pathogen worldwide, with co-infection with HIV and
emergence of multiple drug-resistant strains compounding the
impact. Estimates indicate approximately one-third of world pop-
ulation has immunological evidence of infection with Mtb with
over 10 million new cases each year (Dye et al., 1999). Mtb is a
successful human pathogen because it is able to subvert the host
immune response, often choosing an intracellular lifestyle. At the
same time, the human immune response is largely successful at
containingMtb-infection,due to an effectiveTh1 response, reﬂect-
ing the coordinated action of CD4+ and CD8+ T cell immunity.
While CD4+ T cells play an important role in this process, CD8+
T cells are essential because of their unique ability to recognize
intracellular infection, particularly in those cells that are major
histocompatibility class (MHC)-II negative (Grotzke and Lewin-
sohn, 2005). One critical question that remains unanswered is
how antigens derived from Mtb gain access to the MHC-I antigen
processing and presentation pathway.
Following aerosol exposure, Mtb is taken up by lung-resident
macrophages and dendritic cells (DC),where it resides in a phago-
somal compartment.DCshave been shown toplay an essential role
in the immune response in vivo through cross-presentation and
cross-priming functions (Mellman and Steinman, 2001; Segura
and Villadangos, 2009; Amigorena and Savina, 2010). Although
in vivo studies indicate DCs are involved in the immune response
following infection with Mtb (Tian et al., 2005; Wolf et al., 2007;
Leepiyasakulchai et al., 2012), very little is known about their role
in the initiation of CD8+ T cell responses. In vitro, many studies
have focused on the nature of the Mtb-containing phagosomal
compartment. The consensus in the ﬁeld is that this compartment
does not fuse with lysosomes, but intersects with the endoso-
mal pathways, recruiting molecules and necessary nutrients for
survival and replication (reviewed in Russell, 2001; Philips, 2008).
With regard to MHC-I antigen presentation and initiation of a
CD8+ T cell response, studies indicate the presence of processing
machinery on phagosomes, including MHC-I and the transporter
associated with antigen processing (TAP; Ackerman et al., 2003;
Guermonprez et al., 2003; Houde et al., 2003; Grotzke et al., 2009).
Work by other groups demonstrates that Mtb antigens can access
both cytosolic and vacuolar antigen processing pathways (Maz-
zaccaro et al., 1996; Neyrolles et al., 2001; Schaible et al., 2003;
Lewinsohn et al., 2006).We recently showed that theMtb compart-
ment is a competent MHC-I antigen processing and presentation
organelle. Loaded HLA-E molecules and TAP are present on the
phagosome (Grotzke et al., 2009), and peptide import into the
lumen of the Mtb phagosome occurs (Harriff, M. J., unpublished
data). An alternative model was also proposed that attributes Mtb
antigen presentation on MHC-I molecules and subsequent recog-
nition by CD8+ T cells to the ability of Mtb to escape from its
phagosomal membrane and reside in the cytoplasm (van der Wel
et al., 2007; Weerdenburg et al., 2010).
In this review, we will revisit the literature analyzing the
intracellular localization of Mtb and address potential reasons
for the discrepancies seen in various in vitro and in vivo stud-
ies. Much of our understanding of the intracellular lifestyle of
Mtb is derived from microscopy studies. In particular, electron
microscopy (EM) provides sufﬁcient ultrastructural resolution
to visualize Mtb within vacuolar structures. In addition, many
researchers utilize immuno-ﬂuorescence (IF) microscopy using
antibodies against vacuolar membrane proteins to characterize
the co-localization of these markers with surface-labeled or ﬂuo-
rescent protein-expressing Mtb. Here,we will focus on studies that
document Mtb localization by EM and immuno-EM techniques.
We will then look at how these studies correspond to in vivo analy-
ses of Mtb localization within cells. Finally, we will assess whether
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or not escape from the phagosome is necessary for access of anti-
gen to the MHC-I pathway. If the intracellular lifestyle of Mtb is
critical to recognition of infection by CD8+ T cells, it is imperative
to characterize Mtb localization in cells for better vaccine design
strategies.
INTRACELLULAR LOCALIZATION OF Mtb IN VITRO
Intracellular localization of Mtb within phagocytes has been
observed since the late 1960s and early 1970s. In their sem-
inal study, Armstrong and Hart analyzed mouse peritoneal
macrophages infected with viable or non-viable M. tuberculosis
H37Rv strain and Mycobacterium bovis BCG by EM. They noted
that 4 days post infection,“bacteriawere never seen to be free in the
cytoplasm (i.e., outside phagosomes),” with 23% of these phago-
somes exhibiting lysosomal fusion.Macrocyclonwas subsequently
used to prevent replication of the bacteria. In this case, viable
H37Rv remained in membrane-bound phagosomes out to 14 days
post infection, with 21% fusing with lysosomes (Armstrong and
Hart, 1971).
The ﬁrst reports of Mtb escape from the phagosome were
published in 1980s by the Wright laboratory. Surprisingly, this
group reported that at as early as 18–24 h post infection, as
many as 60–100% of bacteria had escaped the phagosome and
were in the cytosol (Leake et al., 1984; Myrvik et al., 1984). The
reasons for this discrepancy remain unclear, however these studies
differed dramatically between in the species, source, and culti-
vation of macrophages, and the preparation of and multiplicity
of infection (MOI) of the bacterial inoculum. Speciﬁcally, rabbit
alveolar macrophages were infected with H37Rv at higher MOI
(20–25:1) than was used in the Armstrong and Hart (1971) study
(MOI∼5:1). These studies and others describing the intracellular
location of Mtb are summarized in Table 1.
A series of papers published in the 1990s evaluated the precise
intracellular location of Mtb. McDonough et al. (1993) noted that
half of the bacteria infecting J774mousemacrophages had escaped
to the cytosol 4 days following infection. The authors qualiﬁed
their observations by suggesting“one must exercise caution in dis-
tinguishing between a tubercle bacillus free in the cytoplasm and
one which is encased in a tightly apposed vacuolar membrane.”
Subsequent studies by Xu et al. (1994) and Clemens and Horwitz
(1995) addressed this concern using H37Rv-infected mouse bone
marrow-derived macrophages and primary human monocytes,
respectively. Xu et al. observed mycobacteria in a membrane-
bound, LAMP1 positive compartment for as long as 14 days post
infection. In many cases, the membrane was tightly apposed to the
bacteria (Xu et al., 1994). The differences between McDonough
et al. and Xu et al. may reﬂect microscopic technique, since Xu
et al. utilized cryopreservation prior to EM, whereas McDonough
Table 1 | In vitro ultrastructural analyses of Mtb intracellular localization.
Author andYear Journal Cell type Mycobacterial
strain
MOI (if
indicated)
Maximum
length of
infection
% Bacteria
free in the
cytosol
Armstrong and Hart (1971) J. Exp. Med. Mouse peritoneal macrophages H37Rv ∼5:1 14 d 0
Myrvik et al. (1984) Am. Rev. Respir. Dis. Rabbit alveolar macrophages H37Rv 20–25:1 24 h 60–100
H37Ra 20–25:1 24 h <1
Leake et al. (1984) Infect Immun. Rabbit alveolar macrophages H37Rv 20–25:1 18 h 70–99
Rabbit alveolar
macrophages – BCG
immunized
H37Rv 20–25:1 18 h 8–28
McDonough et al. (1993) Infect. Immun. J774 mouse macrophages H37Rv 1–10:1 4 d ∼50
Xu et al. (1994) J. Immunol. Mouse bone marrow-derived
macrophages
H37Rv 10–20:1 14 d 0
Clemens and Horwitz (1995) J. Exp. Med. Primary human monocytes Erdman 0.5:1 5 d 0
Paul et al. (1996) J. Infect. Dis. Human monocyte-derived
macrophages from PBMC
H37Rv 1:1 6 d 0
Mazzaccaro et al. (1996) Proc. Natl. Acad. Scei.
U.S.A.
Mouse bone marrow-derived
macrophages
Erdman 3–10:1 24 h 0
Beatty et al. (2000) Trafﬁc Mouse bone marrow-derived
macrophages
CD1551 (CSU93) 25:1 16 d 0
Clemens et al. (2002) Infect. Immun. Human peripheral blood
mononuclear cells, THP-1
monocytes (human)
Erdman 30:1 3 d 01
van derWel et al. (2007) Cell Human monocyte-derived DC H37Rv 10:1 4 d 322
7 d 572
Peyron et al. (2008) PLoS Pathog. Foamy macrophages (human) H37Rv 1:100 11 d 0
1Determined by ﬂuorescence microscopy, percentage not given for ultrastructural studies.
2Percentage of DC containing cytosolic mycobacteria.
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et al. (1993) used organic solvents to dehydrate the sample. The
use of organic solvents has the potential to extract the phagosomal
membranes and result in the appearance of cytosolic localization.
Studies by Clemens and Horwitz also utilized cryopreservation
and immuno-EM to delineate the intracellular location of Mtb.
In this study, the intracellular compartment of single bacteria ver-
sus multiple bacteria was markedly different. Speciﬁcally, single
bacteria cell were localized to phagosomes that rarely fused with
lysosomes and stained positively for multiple markers, including
MHC-I, MHC-II, and the transferrin receptor (TfR). These bac-
teria were not found free in the cytoplasm out to 5 days post
infection. In contrast, organelles containing multiple mycobac-
teria were observed to fuse with lysosomes, and stained positively
for CD63 (Clemens and Horwitz, 1995).
Subsequent EM experiments revealed Mtb surrounded by a
phagosomal membrane that had not fused with the lysosome. The
studies listed in Table 1 and others have deﬁned the phenotype
of this phagosomal membrane. Many proteins are now com-
monly used markers in the study of host–pathogen interactions
of Mtb and other intracellular bacteria (illustrated schematically
in Figure 1). Identiﬁcation of the vacuolar trafﬁcking proteins
that are acquired and retained or excluded from the Mtb phago-
some deﬁned the point of Mtb phagosome maturation arrest
as the retention of Rab5 and failure to acquire Rab7 or CD63.
While phagosome maturation is arrested, the Mtb-containing
vacuole remains dynamic and fuses with other vacuolar com-
partments. These interactions result in localization of the TfR
and MHC-I to the Mtb phagosome (Clemens and Horwitz, 1995,
1996; Sturgill-Koszycki et al., 1996; Via et al., 1997; Kelley and
Schorey, 2003). The kinetics and mechanisms of molecule traf-
ﬁcking to and from the phagosome, the bacterial protein and
lipid effectors responsible for preventing fusion of Mtb phago-
somes with lysosomes have been extensively reviewed elsewhere
(Deretic et al., 1997; Deretic and Fratti, 1999; Pieters, 2001; Rus-
sell, 2001;Vergne et al., 2004; Brumell and Scidmore, 2007; Philips,
2008).
Recent work by Peter Peters’ group challenged this view and
suggested that the Mtb phagosome fuses with lysosomes early
after infection and that bacteria translocate to the cytosol by 48 h
after infection (van der Wel et al., 2007). In contrast to earlier
work that had focused on macrophages and monocytes, human
monocyte-derivedDC that had been differentiated for 5 days prior
to bacterial infection were employed. Cryo-immunogold EM was
performed at time points from 2 to 96 h following infection. At
early time points Mtb was present in a phagosome characterized
by the presence of CD63, Lamp1, Lamp2, and Cathepsin D, while
MHC-I, TfR, and EEA1 were absent. In spite of the presence of
lysosomal markers, these early organelles did not acidify. At later
time points, the authors observed the gradual accumulation of
Mtb, but not BCG in the cytosol. By 7 days, more than half of the
cells contained cytosolic Mtb. Translocation of Mtb to the cytosol
was dependent on the ESX-1 Type VII secretion system and EspA.
The ESX-1 system is encoded in the region of difference 1 (RD1)
region of the Mtb genome that is missing from BCG. Based on
their data, van der Wel et al. (2007) proposed that Mtb escape
into the cytosol is the primary mechanism by which Mtb antigens
FIGURE 1 | Common markers of the Mtb phagosome.
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access the MHC-I processing pathway (van der Wel et al., 2007;
Weerdenburg et al., 2010).
Preparation of samples for EM, the type and viability of the
host cell, and preparation of the bacterial inoculum may explain
the conﬂicting results regarding phagolysosomal fusion as well
as the escape of Mtb to the cytosol. However, van der Wel et al.
(2007) used state of the art techniques for EM sample preparation
and analysis. Alternatively, it is possible that presence of cytoso-
lic mycobacteria reﬂected the viability of the DC. First, in our
experience, Mtb-infected DC cultured for longer than 7 days have
high levels of cell death, and consequently diminished capacity
for antigen presentation. Second, it has been reported that Mtb-
infection is associated with the death of the host cell. It has been
previously demonstrated that virulent mycobacteria inhibit apop-
tosis. Uptake of Mtb within apoptotic bodies by uninfected cells
is a mechanism by which Mtb growth is inhibited (Keane et al.,
2000). Conversely, the ability to promote macrophage necrosis
is a function of mycobacterial virulence (Hsu et al., 2003; Pan
et al., 2005). The induction of necrotic cell death is postulated to
promote mycobacterial spread. More recently, it has been demon-
strated that high intracellular bacterial burden results in a process
termed “atypical cell death.” This Mtb-induced cell death is char-
acterized by lysosomal membrane permeabilization followed by
degradation of lipid bilayers, and results in morphological charac-
teristics and activation of molecules distinct from apoptosis and
necrosis (Lee et al., 2006, 2011; Park et al., 2006). This elevated
intracellular mycobacterial burden can result from either a high
initial inoculum (Lee et al., 2006), or from ongoing intracellular
bacterial replication (Park et al., 2006), and was associated with
the disruption of phagosomal membranes and free cytosolic Mtb
(Lee et al., 2011). Apoptosis was evaluated by van der Wel et al.
(2007) through examination of Caspase 3 levels using ﬂuorescence
microscopy in conjunction with analysis of the morphological
changes associated with apoptosis by EM. Only 5% of the Mtb-
infected DC were apoptotic at 96 h after infection. However, their
analysis does not provide an estimate of those cells undergoing
atypical and/or necrotic cell death. Although the ability of Mtb to
induce atypical cell death is DC is not known, these data suggest
that the observation of cytosolic Mtb is a reﬂection of atypical cell
death.
Along with virulence and bacterial burden, the preparation
of the inoculum is another possible explanation for discordance
between these studies. As discussed previously, both viability and
homogeneity of the culture can inﬂuence whether or not the Mtb
phagosome will undergo lysosomal fusion. For example, it has
been previously demonstrated that non-viable mycobacteria are
taken up into phagosomes that fuse with lysosomes. As the via-
bility of the inoculum used by van der Wel et al. (2007) was not
indicated, this parameter is difﬁcult to evaluate. Furthermore, tight
apposition of the phagosomal membrane to the mycobacteria is
required to prevent lysosomal fusion (De Chastellier et al., 2009).
In this case evenmodest bacterial clumpingwill result in lysosomal
fusion. The presence of multiple bacteria in a single phagosome at
time points shortly after infection in the van derWel study suggests
these mycobacteria-containing phagosomes will likely fuse with
lysosomes and may explain the discordant protein co-localization
data.
DOES Mtb ESCAPE THE PHAGOSOME IN VIVO?
While in vitro models are invaluable in the study of host–pathogen
interactions, of central importance is the intracellular location
of Mtb in vivo. In humans, surprisingly little is known regard-
ing the intracellular location of Mtb. Following exposure to Mtb,
widely divergent outcomes can occur, ranging from no clinical or
immunologic evidence of exposure, to a state of latency deﬁned
by immunologic evidence of exposure in the absence of clinical
or radiographic manifestations of disease. At present, the means
by which aerosolized Mtb enters the lung is poorly understood.
Furthermore, it is worth noting that in the limited studies using
mycobacterial culture to determine the location of Mtb in those
thought latently infected,Mtb can be observed in both granuloma-
tous tissue and areas of normal lung (Opie and Aronson, 1927).
Ultrastructural analyses of tissues following natural infection of
humans are informative, but limited in scope (Table 2). EM of
bronchoalveolar lavage samples from infected individuals revealed
that Mtb localizes in membrane-bound compartments in infected
alveolar macrophages (Russell et al., 2002; Mwandumba et al.,
2004). These compartments typically contained a single mycobac-
terium with the membrane tightly apposed to the organism. In
some cases of heavy infection, multiple organisms were observed
in a larger compartment. While these studies demonstrate vacuo-
lar Mtb in alveolar macrophages, the intracellular location of Mtb
in alternate cells such as DC and epithelial cells in vivo is not clear.
The mouse model of TB was designed to cause persistent
intracellular infection. Nonetheless, the intracellular localiza-
tion of Mtb has been examined in lung tissue samples from
experimentally infected mice (Table 2). While limited in scope,
ultrastructural analyses of granulomatous lung lesions and lung
homogenates have consistently demonstrated the presence of Mtb
and other virulent mycobacteria in a membrane-bound organelle
(Merckx et al., 1964; Dumont and Sheldon, 1965; Kondo et al.,
1982; Moreira et al., 1997). These studies also revealed hetero-
geneity in the morphology of the Mtb-containing compartment.
In some cases, large membrane-bound vacuoles contained large
numbers of bacteria, and in other cases, bacteria were observed
singly, in phagosomes with tightly apposed membranes. Moreira
et al. (1997) note, however, that multiple mycobacteria per phago-
some were only observed in damaged macrophages at inﬂam-
matory sites. Within the granuloma, Mtb have been observed in
phagosomal compartments in foamy macrophages (Caceres et al.,
2009).
IS ESCAPE FROM THE PHAGOSOME REQUIRED FOR IMMUNE
RECOGNITION?
It has been postulated that escape of Mtb to the cytosol is the
mechanism by which Mtb antigens are processed and presented in
the context of MHC-I. Here, we will address the following ques-
tions: What is the evidence that MHC-I antigens are exported
from the phagosome? Is there enhanced presentation of antigen
or recognition by T cells if Mtb escapes to the cytosol?
In contrast to MHC-II, which samples peptide antigens from
within the endocytic environment, MHC-I is traditionally con-
sidered the primary mechanism by which cytosolically derived
antigen can be processed and presented to T cells. The abil-
ity of specialized antigen presenting cells such as DC to process
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and present antigens derived from non-cytosolic sources in the
context of MHC-I has been termed cross-presentation. Cross-
presentation was originally described by Michael Bevan’s group
(Bevan, 1976; Carbone and Bevan, 1990) and has since been exten-
sively characterized (reviewed in Shen and Rock, 2006; Burgdorf
and Kurts, 2008; Lin et al., 2008; Amigorena and Savina, 2010; Van
Endert, 2011). Kovacsovics-Bankowski and Rock (1995) originally
described the presentation of particulate antigens by demonstrat-
ing that bead-associated OVA could stimulate IFNγ production
by MHC-I restricted T cells. Many of the details of processing and
cross-presentation of antigens have since been elucidated using
inert particles such as latex beads, and it is clear the physical nature
of the antigen has a profound effect on the mechanisms underly-
ing processing and presentation. Particulate antigens taken up in
phagosomes are processed and presented on MHC-I molecules
early after uptake, prior to complete acidiﬁcation of the endo-
cytic compartment (Burgdorf and Kurts, 2008). Soluble antigens,
on the other hand, are taken up into distinct endocytic compart-
ments, mediated by binding to cell-surface receptors that deter-
mine whether or not the antigen will access MHC-I processing
pathways. For example, soluble antigens taken up by the mannose,
Langerin, or DEC-205 receptors are targeted to early endosomes
and presented on MHC-I molecules (Burgdorf and Kurts, 2008).
Once taken up by the cell, both particulate and soluble exogenous
antigens access the cytosol by an undeﬁned mechanism, where
the antigen undergoes proteasomal degradation, TAP-dependent
import into the ER or phagosome, and loading onto MHC-I (Shen
and Rock, 2006). In some cases, antigen remains in the phago-
some/endosome, where it is proteolytically processed for loading
on MHC-I molecules (Lin et al., 2008).
Following infection by intracellular bacterial pathogens, bacte-
rially derived particulate antigens present within the phagosome
can also access the MHC-I processing and presentation pathway
(Ramachandra et al., 2009; Blanchard and Shastri, 2010). This is
in contrast to viral antigens that are present at high levels in the
cytosol and presented via classical MHC-I processing and presen-
tation in the endoplasmic reticulum. The mechanisms by which
antigens from intracellular bacteria are presented have been the
focus of numerous subsequent studies. Although many aspects of
these mechanisms are still under debate, it is clear that bacterially
derived antigens can gain access to the MHC-I pathway in several
distinct, non-mutually exclusive pathways. As noted, these path-
ways have been reviewed extensively andwill be discussed below in
more detail as they pertain speciﬁcally to the Mtb phagosome and
processing and presentation of mycobacterially derived antigens
from this phagosome.
The study of antigen processing and presentation in the con-
text of an intracellular infection such as Mtb can provide unique
insights into these mechanisms. Broadly, these can be divided into
cytosolic and non-cytosolic pathways (Figure 2). The cytosolic
pathway is deﬁned primarily by a requirement for proteasomal
processing, and secondarily for the use of TAP. Direct access of
bacterial antigens into the cytosol would allow for proteasoma-
lly processed peptides to be transported into the ER by TAP,
where they are further processed, loaded onto MHC-I, and sub-
sequently transported to the plasma membrane. Our laboratory
and others have used Mtb-speciﬁc T cell clones to demonstrate
that a number of Mtb antigens access this classical proteasome-
and TAP-dependent cytosolic antigen processing pathway in vitro
(Lewinsohn et al., 1998, 2006; Canaday et al., 1999; Grotzke et al.,
2010). Here, proteasomal blockers including lactacystin, LLnL,
and epoxomicin, were used to show that certain secreted Mtb
proteins, including CFP10, EsxJ, and Ag85B, access the cytosol
and that presentation of these antigens by infected DCs requires
the proteasome. Furthermore, the use of virally encoded pro-
teins that block the ability of TAP to import peptides into the
ER, such as ICP47, indicated that presentation of these same pro-
teins requires TAP. The DCs used in these studies were ﬁxed and
used in ELISPOT assays after less than 18 h of infection with Mtb.
Mycobacterial escape from the phagosome has not been reported
at this time point, indicating that these secreted antigens access
the cytosol without a requirement for bacterial escape. In vivo
data also support a role for TAP in MHC-I presentation of Mtb-
derived antigens. For example, Sousa et al. (2000) used TAP1(−/−)
mice to show that the protective immunity derived from CD8+ T
cells is largely TAP-dependent, although TAP-independent mech-
anisms also contribute to protection. Taken together, these studies
suggest a preferential use of the cytosolic pathway for presentation
of Mtb antigens on MHC-I.
The extent to which particulate phagosomal proteins gain
access to the cytosol and can compete with abundant self proteins
is unclear. As a result, it has been postulated that the phagosome
itself participates in antigen processing and presentation, thus
enhancing the display of these proteins (Gagnon et al., 2002; Ack-
erman et al., 2003; Guermonprez et al., 2003; Houde et al., 2003;
Burgdorf et al., 2008). In contrast to the traditional cytosolic path-
way, antigens transiently access the cytosol and are proteasomally
processed. Peptides are then re-imported via TAP into the phago-
some where they are loaded onto MHC-I. Proteins and molecules
involved in antigen processing and presentation, including TAP,
calnexin, tapasin, calreticulin, ERp57, and MHC-I, are present on
bead phagosomes as well as on Mtb phagosomes (Grotzke et al.,
2009). Providing direct evidence for this alternative phagosome–
cytosolic pathway after Mtb infection, isolated Mtb phagosomes
can directly stimulate IFN-γ production by Mtb-speciﬁc CD8+ T
cells, indicating thepresence of loadedMHC-I complexes (Grotzke
et al., 2009). Additionally, as demonstrated with latex bead phago-
somes (Ackerman et al., 2003), TAP in the Mtb phagosome is
functional for peptide translocation (Harriff, M. J., unpublished
data). Interestingly, ER molecules have also been observed on
phagosomes containing other intracellular pathogens. Goldszmid
et al. (2009) ﬁrst demonstrated the presence of ER markers on the
Toxoplasma gondii parasitophorous vacuole (PV). Further studies
have identiﬁed a role for Sec22b in the recruitment of these ER
proteins to the PV. In the absence of Sec22b, ER-derived proteins
do not access the PV, and cross-presentation of T. gondii anti-
gens is inhibited (Cebrian et al., 2011). While these studies deﬁne
a role for the phagosome in cytosolic processing and loading of
pathogen-derived antigens, they do not provide an estimate of the
extent to which peptides are loaded within the phagosome versus
the ER.
What is the direct evidence that mycobacterial antigens can
access the cytosol? The Bloom laboratory was among the ﬁrst
to show in vitro that cells infected with Mtb could facilitate
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FIGURE 2 | Cytosolic and vacuolar pathways for processing and presenting Mtb antigens in the context of MHC-I.
the presentation of a soluble antigen. Infection of mouse
macrophages with live Mtb led to TAP-dependent presentation
of co-administered soluble OVA (Mazzaccaro et al., 1996). Similar
experiments by this group with wild-type and listeriolysin (LLO)-
deﬁcient Listeria monocytogenes demonstrated LLO-dependent
pore formation was required for the MHC-I presentation of sol-
uble OVA antigen. Taken together, these data led the authors to
postulate a similar mechanism for Mtb (Mazzaccaro et al., 1996).
Subsequently, ﬂuorescent dextrans, ovalbumin, and polystyrene
beads were microinjected into the cytosol of macrophages infected
with live or heat killed BCG. The BCG phagosome was found
to be permeable to molecules up to 70 kDa in size. Uptake of
ﬂuorescent molecules was dependent on viable BCG, suggesting
that BCG actively generates pores in the phagosome (Teitelbaum
et al., 1999). It is unclear, however, what role these pores play
in the access of proteins to the cytosol, as this study demon-
strated unidirectional transport of molecules into the phagosome.
Furthermore, a similar study employing the electroporation of
ﬂuorescently labeled 50 kDa Fab fragments indicated that Mtb
phagosomes are impermeable to these molecules (Clemens et al.,
2002). To evaluate the transport of Mtb-derived antigens from
the phagosome to the cytosol, Schaible et al. co-administered Mtb
with membrane impermeable ﬂuorescent molecules (HPTS and
a FITC-labeled peptide), and found that these molecules did not
access the cytosol. Additionally, after infection with radiolabeled
Mtb, minimal amounts of radiolabeled, Mtb-derived proteins
(<4%) could be found in the cytosol (Schaible et al., 2003).
However, accumulating evidence suggests that certain proteins
can gain access to the cytosol. The well-known antigenic proteins
secreted by the ESX-1 Type VII secretion system, such as CFP10
and ESAT-6 can be found in the cytosol (Abdallah et al., 2007).
Rv1694 (tlyA), a hemolysin and ribosomalRNAmethyltransferase,
can be exported to the cytosol (Rahman et al., 2010), and epitopes
from this protein are recognized by CD8+ T cells in the context
of HLA-A∗0201 (Shams et al., 2003). The tyrosine phosphatase
PtpA can be exported to the cytosol and phagosome membrane,
where it disrupts the trafﬁcking of the V-ATPase complex to the
phagosome (Bach et al., 2006, 2008;Wong et al., 2011). Zmp1 is an
Mtb- and BCG-encoded Zn2+ metalloprotease that interferes with
activation of the inﬂammasome and subsequentmaturation of the
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phagosome. Zmp1 is required for virulence of Mtb in mice and
survival of Mtb and BCG in macrophages and has been observed
in the cytosol of infected cells (Master et al., 2008). These results
suggest that mycobacterial proteins can access the cytosol without
a requirement for Mtb escape from the phagosome
Particulate antigens can also be processed and presented in a
manner that does not require access of proteins into the cytosol.
This pathway has been termed the vacuolar pathway (Figure 2).
Here, the generation of antigenic peptides depends on the presence
of late endocytic peptidases such as cathepsins normally associated
the processing of antigens for MHC-II. It has been postulated that
subsequent loading of these peptides occurs through the exchange
of peptides with MHC-I molecules found within the relatively
acidic endocytic environment (Pfeifer et al., 1993; Song and Hard-
ing, 1996; Chefalo and Harding, 2001; Shen et al., 2004). Neyrolles
et al. (2001) found that the Mtb 19 kDa lipoprotein is trafﬁcked to
distinct compartments from the mycobacteria, and that peptides
derived from the 19 kDa lipoprotein are presented to CD8+ T cells
by a TAP-independent mechanism. Furthermore, Mtb antigens
can also be found in exosomes that are continuously trafﬁcked
from the phagosome as well as apoptotic bodies derived from
infected cells, allowing for the uptake of antigen by uninfected
bystanderAPCs (Beatty and Russell, 2000; Beatty et al., 2000, 2001;
Schaible et al., 2003). The fact that Mtb antigens can be presented
to CD8+ T cells without accessing the cytosol suggests that escape
to the cytosol is not an absolute requirement.
IS RD1/ESX-1 NECESSARY FOR ANTIGEN PRESENTATION?
It is postulated that the ESX-1 secretion system is central to the
escape of Mtb into the cytosol and thereby promotes MHC-I anti-
gen presentation. Currently, there is no experimental evidence
comparing the efﬁciency of CD8+ T cell activation in response to
cytosolic versus phagosomal Mtb. However, there are studies both
in vitro and in vivo that have examined the effect of RD1 deletion
on the acquisition and maintenance of mycobacterially reactive
CD8+ T cells. From these studies it is clear that presence of ESX-
1 is not an absolute requirement for access of Mtb antigens into
the cytosol. We have demonstrated that infection of human DC
with the MtbΔRD1 mutant was as efﬁcient as the complemented
Mtb strain in activating CD8+ T cell clones speciﬁc for the TB8.4
antigen (Lewinsohn et al., 2006). Billeskov et al. (2007) similarly
observed robust induction of TB10.4 speciﬁc CD8+ T cells upon
infection of mice with either wild-type Mtb or the MtbΔRD1
mutant. The ability of speciﬁc mutants of the RD1 region, includ-
ing the ΔespA mutant, to induce antigen-speciﬁc CD8+ T cells
was also unchanged. Woodworth et al. (2008) concluded that Mtb
escape is not required for access of antigen to the MHC-I antigen
processing pathway.
For in vivo experiments, virulence and the association of Mtb-
speciﬁc CD8+ T cells with bacterial burden make interpretation of
these experiments difﬁcult. It is clear that both the virulence and
the induction of CD8+ T cell responses are enhanced when the
RD1 region is restored toBCG(Pymet al., 2003; Brodin et al., 2004;
Majlessi et al., 2005). A number of experiments have addressed the
issue of reduced bacterial burden in BCG-infected animals with
regard to CD8+ T cell activation. Russell et al. (2007) used an OVA
expressing-BCG strain to show that increasing the dose of BCG
leads to a more rapid CD8+ T cell response, due to an increase
in the amount of antigen. Ryan et al. (2009) administered greater
numbers of BCG than Mtb to mice, such that the lymph node
mycobacterial burden was comparable. By establishing equivalent
levels of antigen at the site of T cell priming, functionally equiv-
alent, antigen-speciﬁc CD8+ T cells were induced (Ryan et al.,
2009). Taken together, these data imply that reduced CD8+ T cell
frequencies in response to bacteria lacking RD1 reﬂect decreased
availability of antigen due to lower virulence, as opposed to an
inability of these bacteria to escape to the cytosol.
CONCLUSION
While Mtb is not an obligate intracellular pathogen, its ability to
co-opt the intracellular environment is central to Mtb to persis-
tence in its human host. Maintaining a poorly acidiﬁed phagoso-
mal environment provides protection, nutrients, and many other
beneﬁts to this pathogenic mycobacteria. Conversely, egress of
Mtb into the cytosol with concomitant induction of apoptosis,
autophagy, and atypical cell death are likely critical events in the
interrelationship of pathogen and host, and may eventually be key
to transmission. Mtb is a successful pathogen yet it is also con-
tained by the host to a large extent. Here, it is important for the
immune system to recognize and respond to infected cells. Know-
ing the intracellular niche of Mtb, and understanding how Mtb
antigens are processed and presented to T cells within this con-
text is critical to design of better vaccines. In this review, we have
examined the evidence suggesting that Mtb escapes the phago-
some, and whether or not this is a critical event in the induction
and maintenance of MHC-I dependent immunity.
In vitro, it is clear that although escape of Mtb into the cytosol
is possible, we have an incomplete understanding of the circum-
stances necessary for this to occur. While limited, ultrastructural
evidence does not support the escape of Mtb from the phagosome
in vivo. The presence of Mtb in cytosol could have consequences
both for the host and the microbe. For example, cytosolic Mtb
could lead to stimulation of innate intracellular sensors such as
NOD2. While the presence of NOD2 has not been associated
with mycobacterial growth control in the mouse, it has recently
been shown that NOD2 stimulation can inhibit growth of Mtb
in human macrophages (Brooks et al., 2011). It is also likely that
presence of mycobacteria in the cytosol host cell leads to the death
of this cell. At present, whether this event leads to transmission or
enhanced control is not known.
At present, the evidence from both in vitro and in vivo studies
does not support the case that mycobacterial escape to the cytosol
is necessary for CD8+ T cell recognition. In vivo, while CD8+ T
cell responses are observed at a higher frequency in the presence
of the RD1-associated proteins, it is likely that these differences
are a reﬂection of enhanced antigen load. (Russell et al., 2007;
Woodworth et al., 2008; Ryan et al., 2009) rather than escape to
the cytosol. While an in vivo system does not exist that models
cytosolic Mtb, some insight can be gained from vaccination stud-
ies. The laboratory of Stefan Kaufmann has developed a BCG
vaccine strain that secretes the LLO protein, a protein whose
ability to form pores has been optimized via the deletion of ure-
ase leading to decreased phagosomal acidiﬁcation (Grode et al.,
2005). It was postulated that this strain could allow for more
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efﬁcient egress of mycobacterial proteins and/or the bacterium
itself into the cytosol, and thus improved CD8+ T cell responses.
Indeed, vaccination of mice with this recombinant BCG provides
increased protection against subsequent infection with Mtb, but
the mechanism has not been completely deﬁned. In vitro, there is
increased cytosolic BCG-derived protein. Furthermore, infection
of mouse macrophages with this vaccine strain induces apopto-
sis, possibly leading to cross-priming by bystander APCs via the
uptake of apoptotic vesicles containing mycobacterial antigens
(Grode et al., 2005). As such, it remains unclear as to whether
or not this vaccine leads to improved frequency and/or quality
of the Mtb-speciﬁc CD8+ T cell response, and whether or not
this is responsible for the improved vaccine efﬁcacy that has been
observed.
Based on our understanding of howMtb antigens are processed
and presented in the context of MHC-I to CD8+ T cells in vitro,
and the differences in antigen load and subsequent protection
between Mtb and BCG in vivo, it is our opinion that Mtb escape to
the cytosol is not critical for induction of CD8+ T cell responses.
Rationale vaccine design requires that those CD8+ T cells induced
during the course of vaccination can recognize those cells infected
with Mtb. In this regard, an enhanced understanding of both the
mechanisms of antigen processing and presentation as well as the
repertoire of those antigens is of more than semantic importance.
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